Moving back to basics

22/06/20 -"We have revised our target price and recommendation to incorporate the strong rebound in Kingfisher’s trading performance, amidst the COVID-19 crisis. Moreover, we believe the new turnaround plan ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

22/06/20

Download

You may also be interested by these reports :

21/01/26

Currys

Currys delivered a strong peak trading performance, beating expectations with 6% LFL sales growth, driven by market share gains in both the UK&I and ...

20/01/26

DocMorris

Prel. FY25 sales: Good group sales but Rx sales were softer than expected

14/01/26

Idea Kicker

We turned bullish on Tesco (ADD ; UK) two years ago, arguing that the worst was behind the UK’s largest grocer (c.29% market share). Management had ...

07/01/26

Redcare Pharmacy

Prel. sales FY25 nearly met guidance and market consensus expectations

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue